Gabriela Abigail Ortega Villacreses
Research Subjects
Gabriela Abigail Ortega Villacreses has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Chamorro Barona Angelica Estefania
Médico General. Adscrita del Hospital Gineco Obstétrico Isidro Ayora. Graduada de la Universidad Técnica de Ambato. (Quito-Ecuador)
1 shared publication - Jacqueline Estefanía Alarcón Herrera
Investigador Independiente
1 shared publication - Lema Carrera Mirian Ernestina
Médico General. Adscrita del Hospital Básico Guaranda. Graduada de la Escuela Superior Politécnica de Chimborazo. (Chimbo-Ecuador)
1 shared publication - Lissette Alejandra Tisalema Laura
Hospital del IESS. Ambato
1 shared publication - María Paula Villagomez Mayorga
Hospital General Docente Ambato
1 shared publication - Medina Cobo Myriam Raquel
Médico General. Adscrita del Consultorio Médico Stephen O'connor. Graduada de la Universidad Técnica de Ambato. (Ambato-Ecuador)
1 shared publication
Latest Publications
- Open Access
- 1 July 2026
- Published by Center and Development of Research Projects in Salud Medicina e Innovación Journal
- Vol. 4 (3) , 372-392
REVISIÓN BIBLIOGRÁFICA: Abordaje de las convulsiones en pediatría: criterios para el tratamiento farmacológico inmediato, la vigilancia clínica y la observación hospitalaria
Introduction: Seizures are among the most common neurological emergencies in childhood. Accurately determining which patients require long-term antiseizure medication (ASM) therapy and which may be managed exclusively through clinical observation remains a significant clinical challenge. Objective: To analyze and standardize the clinical, electroencephalographic, and neuroimaging criteria used to distinguish pediatric patients with seizures who require pharmacological treatment from those who may be managed through observation. Methods: A systematic exploratory search was conducted in indexed databases, including PubMed, ScienceDirect, SciELO, and the Cochrane Library, using DeCS/MeSH terms. Clinical practice guidelines, meta-analyses, and clinical trials published between 2021 and 2026 were selected. Results: The available evidence indicates that a first unprovoked seizure is associated with a recurrence risk of approximately 40–50%; therefore, close clinical observation is generally the preferred management strategy. Long-term pharmacological treatment is indicated when the estimated risk of recurrence exceeds 60%, particularly in the presence of clear epileptiform discharges on electroencephalography, an abnormal baseline neurological examination, structural abnormalities on neuroimaging, or status epilepticus at presentation. Conclusion: In pediatric patients, the decision to initiate antiseizure therapy should not be determined by the dramatic clinical appearance of the first seizure. Instead, it should be based on an objective assessment of recurrence risk and a careful evaluation of the benefit–risk profile of antiseizure medications (American Academy of Pediatrics, 2022; Berg et al., 2022; National Institute for Health and Care Excellence, 2022).
- 1 July 2026
- Published by Center and Development of Research Projects in Salud Medicina e Innovación Journal
- Vol. 4 (3) , 372-392
Open AccessREVISIÓN BIBLIOGRÁFICA: Abordaje de las convulsiones en pediatría: criterios para el tratamiento farmacológico inmediato, la vigilancia clínica y la observación hospitalaria
Introduction: Seizures are among the most common neurological emergencies in childhood. Accurately determining which patients require long-term antiseizure medication (ASM) therapy and which may be managed exclusively through clinical observation remains a significant clinical challenge. Objective: To analyze and standardize the clinical, electroencephalographic, and neuroimaging criteria used to distinguish pediatric patients with seizures who require pharmacological treatment from those who may be managed through observation. Methods: A systematic exploratory search was conducted in indexed databases, including PubMed, ScienceDirect, SciELO, and the Cochrane Library, using DeCS/MeSH terms. Clinical practice guidelines, meta-analyses, and clinical trials published between 2021 and 2026 were selected. Results: The available evidence indicates that a first unprovoked seizure is associated with a recurrence risk of approximately 40–50%; therefore, close clinical observation is generally the preferred management strategy. Long-term pharmacological treatment is indicated when the estimated risk of recurrence exceeds 60%, particularly in the presence of clear epileptiform discharges on electroencephalography, an abnormal baseline neurological examination, structural abnormalities on neuroimaging, or status epilepticus at presentation. Conclusion: In pediatric patients, the decision to initiate antiseizure therapy should not be determined by the dramatic clinical appearance of the first seizure. Instead, it should be based on an objective assessment of recurrence risk and a careful evaluation of the benefit–risk profile of antiseizure medications (American Academy of Pediatrics, 2022; Berg et al., 2022; National Institute for Health and Care Excellence, 2022).
- 1 September 2024
- Published by Revista Sanitaria de Investigación in Revista sanitaria de investigación
- Vol. V (09)
CARACTERIZACIÓN Y EPIDEMIOLOGÍA DE LAS INFECCIONES PARASITARIAS DE LA PIEL. UN ANÁLISIS COMPLETO DE LA PREVALENCIA, LOS FACTORES DE RIESGO Y LAS OPCIONES DE TRATAMIENTO
Nº de DOI: 10.34896/RSI.2024.45.22.001 AUTORES Geanella Amada Palacios Calderón. Médico General. Adscrita del Hospital General Docente de Calderón. Investigadora Independiente del Departamento de Docencia e Investigación Matilde Hidalgo de Procel. Egresada de la Universidad Católica de Santiago de Guayaquil. (Quito-Ecuador). https://orcid.org/0009-0004-5865-2789 Steven René Quezada Terán. Médico General. Adscrito a Clínicas […]
- 1 September 2024
- Published by Revista Sanitaria de Investigación in Revista sanitaria de investigación
- Vol. V (09)
CARACTERIZACIÓN Y EPIDEMIOLOGÍA DE LAS INFECCIONES PARASITARIAS DE LA PIEL. UN ANÁLISIS COMPLETO DE LA PREVALENCIA, LOS FACTORES DE RIESGO Y LAS OPCIONES DE TRATAMIENTO
Nº de DOI: 10.34896/RSI.2024.45.22.001 AUTORES Geanella Amada Palacios Calderón. Médico General. Adscrita del Hospital General Docente de Calderón. Investigadora Independiente del Departamento de Docencia e Investigación Matilde Hidalgo de Procel. Egresada de la Universidad Católica de Santiago de Guayaquil. (Quito-Ecuador). https://orcid.org/0009-0004-5865-2789 Steven René Quezada Terán. Médico General. Adscrito a Clínicas […]